Both in Pharmaceuticals
AB Corporate Bond ETF vs Innovator U.S. Equity Ultra Buffer ETF - November
Over the past year EYEG returned −7.0% and UNOV returned +10.0%; their daily moves had a correlation of 0.38.
EYEG −7.0% UNOV +10.0%Growth of $1, one year, split-adjusted
| Metric | EYEG | UNOV |
|---|---|---|
| Price | $33.54 | $41.63 |
| Market cap | $26.8M | $111.4M |
| Today | −0.67% | −0.12% |
| 1 month | +0.1% | 0.0% |
| 6 months | −4.7% | +4.5% |
| Year to date | −6.2% | +9.4% |
| 1 year | −7.1% | +10.0% |
| Revenue growth (YoY) | — | −19.3% |
| Gross margin | — | 68.5% |
| Net margin | — | 11.4% |
| P/E (TTM) | — | 29.7× |
| Price / sales | — | 3.3× |
| Net cash | $16.8M | $2.7M |
| Dividend yield | 5.22% | — |
| Volatility (60d) | 5.5% | 7.0% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).